Catalyst Pharmaceuticals Inc

CPRX

Get informed when a big investor buys or sells

Market Cap$3.85B

Close$

Compare to Similar Companies

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
Catalyst Pharmaceuticals Inc	17.5	-	22%	7.9	-

$31.75

Target Price by Analysts

0.8% upsideCatalyst Pharmaceuticals Target Price Details

$16.80

Current Fair Value

46.7% downside

Overvalued by 46.7% based on the discounted cash flow analysis.

Share Statistics

Market cap	$3.85 Billion
Enterprise Value	$3.10 Billion
Dividend Yield	$- (-)
Earnings per Share	$1.75
Beta	0.74
Outstanding Shares	122,254,171

Return

Return on Equity	21.85%
Return on Assets	19.29%
Return on Invested Capital	27.65%

Valuation & Multiples

P/E Ratio	17.49
PEG	141.86
Price to Sales	7.87
Price to Book Ratio	3.94
Enterprise Value to Revenue	5.2
Enterprise Value to EBIT	11.05
Enterprise Value to Net Income	14
Total Debt to Enterprise	0
Debt to Equity	0

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date

August 5, 2026

EPS Estimate

$0.48

Average shareholder expectation

Revenue Estimate

$155.79 M

Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio	1.8242▲ 51.01%
Total Calls	45,500▼ 61.38%
Total Puts	83,000▼ 46.38%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %	85.90%▲ 0.38%
Total Invested	$3.30B▲ 27.51%
Investors Holding	3880%

ESG Score